{"transactions":[{"id":2629410,"issuer":{"id":3796,"kind":"organization","name":"Erasca, Inc."},"owners":[{"id":38112,"kind":"person","name":"Lim Jonathan E","position":1,"cik":"0001283290","reported_name":"Lim Jonathan E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}},{"id":137215,"kind":"person","name":"Lim Conyee T.","position":2,"cik":"0001872346","reported_name":"Lim Conyee T.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137216,"kind":"organization","name":"City Hill, LLC","position":3,"cik":"0001872305","reported_name":"City Hill, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-2 Preferred Stock","published_at":"2021-07-21T00:58:45.000Z","date":"2021-07-20","kind":"exercise","acquired":false,"shares":112000,"ownership":{"direct":false,"nature":"By City Hill, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's Series A and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 1.2-for-1 share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of the Issuer's Series A and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 1.2-for-1 share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares of the Issuer's Series A and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 1.2-for-1 share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Consists of shares held directly by City Hill, LLC (\"City Hill\"). Jonathan E. Lim, M.D. serves as the managing partner of City Hill. Dr. Lim exercises voting and dispositive control over the securities held by City Hill and is therefore deemed to be a beneficial owner of securities owned by City Hill. Dr. Lim disclaims beneficial ownership of the reported securities held by City Hill, except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":93333},"source":{"system":"sec-edgar","filing":"0000899243-21-029085","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1872305/000089924321029085/doc4.xml","form_type":"4"}},{"id":2629409,"issuer":{"id":3796,"kind":"organization","name":"Erasca, Inc."},"owners":[{"id":38112,"kind":"person","name":"Lim Jonathan E","position":1,"cik":"0001283290","reported_name":"Lim Jonathan E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}},{"id":137215,"kind":"person","name":"Lim Conyee T.","position":2,"cik":"0001872346","reported_name":"Lim Conyee T.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137216,"kind":"organization","name":"City Hill, LLC","position":3,"cik":"0001872305","reported_name":"City Hill, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Preferred Stock","published_at":"2021-07-21T00:58:45.000Z","date":"2021-07-20","kind":"exercise","acquired":false,"shares":336000,"ownership":{"direct":false,"nature":"By City Hill, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's Series A and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 1.2-for-1 share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of the Issuer's Series A and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 1.2-for-1 share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares of the Issuer's Series A and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 1.2-for-1 share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Consists of shares held directly by City Hill, LLC (\"City Hill\"). Jonathan E. Lim, M.D. serves as the managing partner of City Hill. Dr. Lim exercises voting and dispositive control over the securities held by City Hill and is therefore deemed to be a beneficial owner of securities owned by City Hill. Dr. Lim disclaims beneficial ownership of the reported securities held by City Hill, except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":280000},"source":{"system":"sec-edgar","filing":"0000899243-21-029085","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1872305/000089924321029085/doc4.xml","form_type":"4"}},{"id":2629408,"issuer":{"id":3796,"kind":"organization","name":"Erasca, Inc."},"owners":[{"id":38112,"kind":"person","name":"Lim Jonathan E","position":1,"cik":"0001283290","reported_name":"Lim Jonathan E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}},{"id":137215,"kind":"person","name":"Lim Conyee T.","position":2,"cik":"0001872346","reported_name":"Lim Conyee T.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137216,"kind":"organization","name":"City Hill, LLC","position":3,"cik":"0001872305","reported_name":"City Hill, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-07-21T00:58:45.000Z","date":"2021-07-20","kind":"exercise","acquired":false,"shares":6081233,"ownership":{"direct":false,"nature":"By City Hill, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's Series A and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 1.2-for-1 share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of the Issuer's Series A and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 1.2-for-1 share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares of the Issuer's Series A and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 1.2-for-1 share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Consists of shares held directly by City Hill, LLC (\"City Hill\"). Jonathan E. Lim, M.D. serves as the managing partner of City Hill. Dr. Lim exercises voting and dispositive control over the securities held by City Hill and is therefore deemed to be a beneficial owner of securities owned by City Hill. Dr. Lim disclaims beneficial ownership of the reported securities held by City Hill, except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":5067694},"source":{"system":"sec-edgar","filing":"0000899243-21-029085","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1872305/000089924321029085/doc4.xml","form_type":"4"}},{"id":2629407,"issuer":{"id":3796,"kind":"organization","name":"Erasca, Inc."},"owners":[{"id":38112,"kind":"person","name":"Lim Jonathan E","position":1,"cik":"0001283290","reported_name":"Lim Jonathan E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}},{"id":137215,"kind":"person","name":"Lim Conyee T.","position":2,"cik":"0001872346","reported_name":"Lim Conyee T.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137216,"kind":"organization","name":"City Hill, LLC","position":3,"cik":"0001872305","reported_name":"City Hill, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-07-21T00:58:45.000Z","date":"2021-07-20","kind":"exercise","acquired":false,"shares":6162468,"ownership":{"direct":false,"nature":"By the Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's Series A and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 1.2-for-1 share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of the Issuer's Series A and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 1.2-for-1 share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares of the Issuer's Series A and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 1.2-for-1 share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein may be deemed beneficially owned by each of (i) Jonathan E. Lim, M.D. and (ii) Conyee T. Lim, M.D., who are co-trustees of the Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":5135390},"source":{"system":"sec-edgar","filing":"0000899243-21-029085","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1872305/000089924321029085/doc4.xml","form_type":"4"}},{"id":2629406,"issuer":{"id":3796,"kind":"organization","name":"Erasca, Inc."},"owners":[{"id":38112,"kind":"person","name":"Lim Jonathan E","position":1,"cik":"0001283290","reported_name":"Lim Jonathan E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}},{"id":137215,"kind":"person","name":"Lim Conyee T.","position":2,"cik":"0001872346","reported_name":"Lim Conyee T.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137216,"kind":"organization","name":"City Hill, LLC","position":3,"cik":"0001872305","reported_name":"City Hill, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-21T00:58:45.000Z","date":"2021-07-20","kind":"exercise","acquired":true,"shares":5441027,"ownership":{"direct":false,"nature":"By City Hill, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's Series A and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 1.2-for-1 share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Consists of shares held directly by City Hill, LLC (\"City Hill\"). Jonathan E. Lim, M.D. serves as the managing partner of City Hill. Dr. Lim exercises voting and dispositive control over the securities held by City Hill and is therefore deemed to be a beneficial owner of securities owned by City Hill. Dr. Lim disclaims beneficial ownership of the reported securities held by City Hill, except to the extent of his pecuniary interest therein."}],"balance_after":11899360,"source":{"system":"sec-edgar","filing":"0000899243-21-029085","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872305/000089924321029085/doc4.xml","form_type":"4"}},{"id":2629405,"issuer":{"id":3796,"kind":"organization","name":"Erasca, Inc."},"owners":[{"id":38112,"kind":"person","name":"Lim Jonathan E","position":1,"cik":"0001283290","reported_name":"Lim Jonathan E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}},{"id":137215,"kind":"person","name":"Lim Conyee T.","position":2,"cik":"0001872346","reported_name":"Lim Conyee T.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137216,"kind":"organization","name":"City Hill, LLC","position":3,"cik":"0001872305","reported_name":"City Hill, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-21T00:58:45.000Z","date":"2021-07-20","kind":"exercise","acquired":true,"shares":5135390,"ownership":{"direct":false,"nature":"By Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's Series A and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 1.2-for-1 share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein may be deemed beneficially owned by each of (i) Jonathan E. Lim, M.D. and (ii) Conyee T. Lim, M.D., who are co-trustees of the Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005."}],"balance_after":20156222,"source":{"system":"sec-edgar","filing":"0000899243-21-029085","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872305/000089924321029085/doc4.xml","form_type":"4"}}]}